128 related articles for article (PubMed ID: 2891026)
1. In vitro study of alpha 2-adrenoceptor turnover and metabolism using the adenocarcinoma cell line HT29.
Paris H; Taouis M; Galitzky J
Mol Pharmacol; 1987 Nov; 32(5):646-54. PubMed ID: 2891026
[TBL] [Abstract][Full Text] [Related]
2. Alpha 2-adrenergic receptor turnover in adipose tissue and kidney: irreversible blockade of alpha 2-adrenergic receptors by benextramine.
Taouis M; Berlan M; Lafontan M
Mol Pharmacol; 1987 Jan; 31(1):89-96. PubMed ID: 2880286
[TBL] [Abstract][Full Text] [Related]
3. Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine.
McKernan RM; Strickland WR; Insel PA
Mol Pharmacol; 1988 Jan; 33(1):51-7. PubMed ID: 2826999
[TBL] [Abstract][Full Text] [Related]
4. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
Paris H; Galitzky J; Senard JM
Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632
[TBL] [Abstract][Full Text] [Related]
5. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
Turner JT; Ray-Prenger C; Bylund DB
Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671
[TBL] [Abstract][Full Text] [Related]
6. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
Lenox RH; Ellis J; Van Riper D; Ehrlich YH
Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397
[TBL] [Abstract][Full Text] [Related]
7. Evidence against the "spare" receptor nature of alpha 2-adrenoceptors in hamster white fat cells.
Dieudonne MN; Pecquery R; Giudicelli Y
Biochem Int; 1990; 20(4):779-86. PubMed ID: 1972326
[TBL] [Abstract][Full Text] [Related]
8. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
Bodenstein J; Venter DP; Brink CB
J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
[TBL] [Abstract][Full Text] [Related]
9. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
McKernan RM; Howard MJ; Motulsky HJ; Insel PA
Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
[TBL] [Abstract][Full Text] [Related]
10. Long term treatment with desipramine increases the turnover of alpha 2-adrenoceptors in the rat brain.
Barturen F; Garcia-Sevilla JA
Mol Pharmacol; 1992 Nov; 42(5):846-55. PubMed ID: 1359398
[TBL] [Abstract][Full Text] [Related]
11. Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists.
Galitzky J; Mauriege P; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1989 May; 249(2):583-91. PubMed ID: 2566681
[TBL] [Abstract][Full Text] [Related]
12. Turnover in vivo of alpha 1-adrenergic receptors in rat submaxillary glands.
Sladeczek F; Bockaert J
Mol Pharmacol; 1983 Mar; 23(2):282-8. PubMed ID: 6300639
[TBL] [Abstract][Full Text] [Related]
13. Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptor metabolism in a muscle cell line, BC3H-1.
Hughes RJ; Insel PA
Mol Pharmacol; 1986 Jun; 29(6):521-30. PubMed ID: 3012317
[TBL] [Abstract][Full Text] [Related]
14. Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line.
Murphy TJ; Bylund DB
J Pharmacol Exp Ther; 1988 Feb; 244(2):571-8. PubMed ID: 2894455
[TBL] [Abstract][Full Text] [Related]
15. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
[TBL] [Abstract][Full Text] [Related]
16. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
Neve KA; Molinoff PB
Mol Pharmacol; 1986 Aug; 30(2):104-11. PubMed ID: 3016496
[TBL] [Abstract][Full Text] [Related]
17. Responses to norepinephrine resistant to inhibition by alpha and beta adrenoceptor antagonists.
Bond RA; Charlton KG; Clarke DE
J Pharmacol Exp Ther; 1986 Feb; 236(2):408-15. PubMed ID: 2868118
[TBL] [Abstract][Full Text] [Related]
18. Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
Snavely MD; Insel PA
Mol Pharmacol; 1982 Nov; 22(3):532-46. PubMed ID: 6296651
[TBL] [Abstract][Full Text] [Related]
19. The effects of tetramethylpyrazine on the human platelet alpha 2 adrenergic receptor adenylate cyclase system.
Hui KK; Yu JL; Tse E; Borst S
Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):3-14. PubMed ID: 2829329
[TBL] [Abstract][Full Text] [Related]
20. Insights into the unusual alpha adrenoceptor subtype in dog saphenous vein using phenoxybenzamine.
Low AM; Lu-Chao H; Loke JC; Kwan CY; Daniel EE
J Pharmacol Exp Ther; 1999 Jan; 288(1):148-56. PubMed ID: 9862765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]